GPSC Associate Professor Result 2021: Gujarat Public Service Commission (GPSC) has declared the result for the Associate Professor, Pharmacology, General State Service, Class-1 post on 21 May 2021.
All such candidates who have applied for the Associate Professor, Pharmacology post can check the result available on the official website of Gujarat Public Service Commission i.e.gpsc.gujarat.gov.in.
Gujarat Public Service Commission (GPSC) has uploaded the list of eligible candidates for application scrutiny for Associate Professor, Pharmacology post against advertisement No. 53/2019-20. Candidates applied for the Associate Professor, Pharmacology, General State Service, Class-1 Health and Family Welfare Department can check the provisional result available on the official website.
It is noted that Gujarat Public Service Commission (GPSC) has invited applications for the Associate Professor, Pharmacology, General State Service, Class-1 posts under Health and Family Welfare Department. All such candidates applied for the Associate Professor, Pharmacology post can check the provisional result available on the official website. You can check the provisional result also with the dirct link given below.
Direct Link for GPSC Provisional Result 2021 for Associate Professor Pharmacology Post
You May Read Also
HPPSC Recruitment 2021: Apply for Administrative/Police Services, Tehsildar and other Posts
Government Jobs 2020 LIVE Updates: MMRDA, TMC, TANGEDCO Jobs
How to Download: GPSC Provisional Result 2021 for Associate Professor Pharmacology Post
- Visit the official website of Gujarat Public Service Commission (GPSC) i.e-gpsc.gujarat.gov.in
- Go to the News & Events List section of the Home Page.
- Click on the link-List of Eligible Candidates for Applicn. Scrutiny 53/2019-20 Associate Professor, Pharmacology, General State Service, Class-1 Class-1 View attachmentgiven on the Home Page.
- You will get the PDF of the desired Result in a new window.
- Candidates should take Print Out of PDF and save a copy for future reference.
Comments
All Comments (0)
Join the conversation